Total Payments
$1,189
2024 Payments
$18.42
Companies
11
Transactions
82
Medicare Patients
620
Medicare Billing
$119,043
Payment Breakdown by Category
Food & Beverage$1,189 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,189 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $374.83 | 27 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $341.83 | 24 | $0 (2024) |
| Lundbeck LLC | $158.83 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $86.41 | 6 | $0 (2023) |
| Alkermes, Inc. | $84.62 | 5 | $0 (2023) |
| Allergan Inc. | $39.72 | 3 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $33.65 | 2 | $0 (2018) |
| ITI, Inc. | $29.02 | 2 | $0 (2020) |
| Kaleo, Inc. | $14.93 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $14.22 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.42 | 1 | Otsuka America Pharmaceutical, Inc. ($18.42) |
| 2023 | $178.27 | 11 | AbbVie Inc. ($63.16) |
| 2022 | $233.41 | 16 | ABBVIE INC. ($146.77) |
| 2021 | $193.86 | 15 | AbbVie Inc. ($164.90) |
| 2020 | $90.41 | 6 | Alkermes, Inc. ($35.04) |
| 2019 | $163.93 | 12 | Otsuka America Pharmaceutical, Inc. ($82.57) |
| 2018 | $188.90 | 14 | Otsuka America Pharmaceutical, Inc. ($60.22) |
| 2017 | $121.45 | 7 | Lundbeck LLC ($84.13) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Neuroscience | ||||||
| 04/27/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CNS | ||||||
| 02/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CNS | ||||||
| 01/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Neuroscience | ||||||
| 06/27/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 112 | 277 | $81,574 | $20,728 |
| 2022 | 4 | 145 | 333 | $126,453 | $31,008 |
| 2021 | 4 | 165 | 366 | $123,737 | $31,757 |
| 2020 | 6 | 198 | 385 | $128,673 | $35,549 |
Total Patients
620
Total Services
1,361
Medicare Billing
$119,043
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 219 | $52,560 | $14,589 | 27.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 36 | 36 | $12,888 | $3,472 | 26.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $16,126 | $2,668 | 16.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 216 | $74,088 | $18,629 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 39 | $28,453 | $6,293 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 40 | 44 | $15,752 | $4,003 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 34 | $8,160 | $2,082 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 59 | 183 | $62,769 | $16,206 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 109 | $26,160 | $6,723 | 25.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 27 | $17,982 | $4,538 | 25.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 43 | 47 | $16,826 | $4,290 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 57 | 176 | $60,207 | $15,692 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 30 | $19,980 | $5,088 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 36 | 76 | $18,240 | $4,711 | 25.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 47 | 49 | $17,496 | $4,623 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 41 | $8,200 | $3,811 | 46.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $4,550 | $1,624 | 35.7% |
About Dr. Elda Sancho Mora, M.D
Dr. Elda Sancho Mora, M.D is a Psychiatry healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003972423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elda Sancho Mora, M.D has received a total of $1,189 in payments from pharmaceutical and medical device companies, with $18.42 received in 2024. These payments were reported across 82 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,189).
As a Medicare-enrolled provider, Sancho Mora has provided services to 620 Medicare beneficiaries, totaling 1,361 services with total Medicare billing of $119,043. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Forensic Psychiatry
- Location Morris Plains, NJ
- Active Since 12/29/2006
- Last Updated 01/10/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1003972423
Products in Payments
- VRAYLAR (Drug) $414.55
- REXULTI (Drug) $223.39
- ABILIFY MAINTENA (Drug) $200.91
- INVEGA SUSTENNA (Drug) $73.04
- TRINTELLIX (Drug) $62.92
- LYBALVI (Drug) $35.62
- Vivitrol (Drug) $35.04
- INGREZZA (Drug) $33.65
- CAPLYTA (Drug) $29.02
- Evzio (Drug) $14.93
- LATUDA (Drug) $14.22
- ARISTADA (Drug) $13.96
- ABILIFY MYCITE (Drug) $13.44
- SPRAVATO (Drug) $13.37
- Trintellix (Drug) $10.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Morris Plains
Joselito Domingo, M.d, M.D
Psychiatry — Payments: $808.40
Psychiatry $808.40
Manjula Kumar, M.d, M.D
Psychiatry — Payments: $287.31
Psychiatry $287.31
Dr. Edward Collopy, M.d, M.D
Psychiatry — Payments: $222.70
Psychiatry $222.70
Marie Rabanal, M.d, M.D
Psychiatry — Payments: $178.73
Psychiatry $178.73
Dr. Inderpal Bhathal, Md, MD
Psychiatry — Payments: $85.03
Psychiatry $85.03
Dr. David Mayerhoff, M.d, M.D
Psychiatry — Payments: $31.74
Psychiatry $31.74